NCT03151811
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03151811
Title A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide (OCEAN)
Acronym OCEAN
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Oncopeptides AB
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ROU | POL | NOR | NLD | LTU | ITA | ISR | HUN | GRC | GBR | FRA | EST | ESP | DNK | CZE | BEL | AUT

Facility Status City State Zip Country Details
US17 Tucson Arizona 85711 United States Details
US01 Fresno California 93710 United States Details
US11 Gainesville Florida 32610 United States Details
US12 Orange City Florida 32763 United States Details
US-19 Plantation Florida 33324 United States Details
US16 Boise Idaho 83712 United States Details
US-24 Louisville Kentucky 40207 United States Details
US13 Boston Massachusetts 02215 United States Details
US-27 Hattiesburg Mississippi 39401 United States Details
US-21 Salisbury North Carolina 28144 United States Details
US-30 Winston-Salem North Carolina 27103 United States Details
US06 Philadelphia Pennsylvania 19107 United States Details
US15 Fort Sam Houston Texas 78234 United States Details
US-18 Temple Texas 76504 United States Details
AT-02 Linz Austria Details
AT-01 Vienna Austria Details
BE-05 Edegem Belgium Details
BE-03 Liège Belgium Details
BE-02 Roeselare Belgium Details
CZ-05 Brno Czechia Details
CZ-03 Hradec Králové Czechia Details
CZ-04 Olomouc Czechia Details
CZ-01 Ostrava Czechia Details
Cz-02, Cz-06 Prague Czechia Details
DK01 Vejle Denmark Details
EE-01 Tallinn Estonia Details
EE-02 Tartu Estonia Details
FR04 Brest France Details
FR-11 Cholet France Details
FR01 Le Mans France Details
FR05 Limoges France Details
FR-07 Lyon France Details
FR06 Lyon France Details
FR03 Mulhouse France Details
FR-09 Nice France Details
FR-10 Périgueux France Details
FR-08 Poitiers France Details
Gr02, Gr03 Athens Greece Details
GR04 Pátrai Greece Details
GR01 Thessaloniki Greece Details
Hu02, Hu03, Hu04 Budapest Hungary Details
HU01 Debrecen Hungary Details
HU-06 Kaposvár Hungary Details
HU-05 Pécs Hungary Details
IL03 Jerusalem Israel Details
IL01 Nahariya Israel Details
IL05 Rehovot Israel Details
IL02 Safed Israel Details
IL04 Tel Aviv Israel Details
IL06 Tel Aviv Israel Details
IT07 Bergamo Italy Details
IT02 Bologna Italy Details
IT08 Brescia Italy Details
It03, It09 Milan Italy Details
IT06 Modena Italy Details
IT04 Piacenza Italy Details
IT05 Terni Italy Details
IT01 Torino Italy Details
LT-02 Kaunas Lithuania Details
LT-01 Vilnius Lithuania Details
NL01 Rotterdam Netherlands Details
NO-02 Ålesund Norway Details
NO01 Oslo Norway Details
PL03 Bialystok Poland Details
PL02 Chorzów Poland Details
PL06 Lodz Poland Details
PL05 Lublin Poland Details
PL-08 Olsztyn Poland Details
PL07 Poznan Poland Details
PL04 Rzeszów Poland Details
PL-09 Torun Poland Details
RO-02 Brasov Romania Details
RO-01 Bucharest Romania Details
RU-04 Izhevsk Russia Details
Ru-11, Ru-14 Krasnoyarsk Russia Details
RU-03 Moscow Russia Details
RU-09 Nizhny Novgorod Russia Details
RU-10 Novosibirsk Russia Details
RU-06 Petrozavodsk Russia Details
Ru-01, Ru-02, Ru-08, Ru-12, Ru-14 Saint Petersburg Russia Details
RU-07 Samara Russia Details
RU-13 Syktyvkar Russia Details
RU-05 Yekaterinburg Russia Details
KR-06 Busan South Korea Details
KR-05 Daegu South Korea Details
KR-04 Hwasun South Korea Details
Kr-01, Kr-02, Kr-03 Seoul South Korea Details
ES11 Badalona Spain Details
Es02, Es13, Es14 Barcelona Spain Details
Es01, Es04, Es09 Madrid Spain Details
ES-15 Málaga Spain Details
Es07, Es12 Pamplona Spain Details
ES10 Salamanca Spain Details
ES03 Santa Cruz de Tenerife Spain Details
ES08 Seville Spain Details
Es05, Es06 Valencia Spain Details
TW-02 Chiayi City Taiwan Details
Tw-04, Tw-07 Kaohsiung City Taiwan Details
TW-03 Taichung Taiwan Details
TW-05 Tainan Taiwan Details
Tw-01, Tw-06 Taipei Taiwan Details
GB03 Liverpool United Kingdom Details
GB01 Manchester United Kingdom Details
GB02 Milton Keynes United Kingdom Details
GB04 Southampton United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field